Segment Information (Tables)

9 Months Ended

Sep. 27, 2013

Segment Reporting, Measurement Disclosures [Abstract]

Segment results are shown below ($ in millions):



	Three Months Ended						Nine Months Ended
	September 27, 2013			September 28, 2012			September 27, 2013			September 28, 2012
Sales:
Test & Measurement	$	808.6		$	814.5		$	2,519.0		$	2,517.3
Environmental	828.7			754.4			2,380.8			2,212.9
Life Sciences & Diagnostics	1,675.1			1,518.1			4,916.8			4,647.4
Dental	510.2			488.9			1,504.7			1,452.4
Industrial Technologies	846.5			839.6			2,530.0			2,455.2
	$	4,669.1		$	4,415.5		$	13,851.3		$	13,285.2

Operating Profit:
Test & Measurement	$	155.0		$	163.6		$	520.7		$	539.4
Environmental	171.6			162.4			485.6			456.6
Life Sciences & Diagnostics	246.8			185.6			686.8			599.4
Dental	82.2			76.0			223.9			206.5
Industrial Technologies	191.7			183.5			566.7			531.6
Equity method earnings of Apex joint venture	—			18.5			—			50.9
Other	(34.9		)	(33.8		)	(96.8		)	(82.4		)
	$	812.4		$	755.8		$	2,386.9		$	2,302.0

- Definition

Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss.

+ References+ Details